Salim Syed
Stock Analyst at Mizuho Securities
(2.58)
# 2,900
Out of 4,504 analysts
1105
Total ratings
44.6%
Success rate
0.9%
Average return
Main Sectors:
Stocks Rated by Salim Syed
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYTK Cytokinetics | Maintained: Buy | $100 → $118 | $84.87 | +39.04% | 146 | Jun 23, 2026 | |
| KURA Kura Oncology | Maintained: Buy | $25 | $11.45 | +118.34% | 9 | Jun 23, 2026 | |
| MAZE Maze Therapeutics | Maintained: Buy | $97 | $30.57 | +217.30% | 4 | Jun 23, 2026 | |
| IOVA Iovance Biotherapeutics | Maintained: Buy | $10 | $4.23 | +136.41% | 5 | Jun 22, 2026 | |
| NKTX Nkarta | Maintained: Buy | $12 | $2.97 | +304.04% | 42 | Jun 22, 2026 | |
| AMGN Amgen | Maintained: Hold | $303 | $363.39 | -16.62% | 171 | Jun 21, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $96 | $85.89 | +11.77% | 107 | Jun 21, 2026 | |
| INCY Incyte | Maintained: Buy | $121 | $116.71 | +3.68% | 7 | Jun 18, 2026 | |
| ATRA Atara Biotherapeutics | Maintained: Buy | $18 | $9.76 | +84.43% | 81 | Jun 18, 2026 | |
| PCVX Vaxcyte | Maintained: Buy | $163 | $58.21 | +180.02% | 24 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $236 → $221 | $199.15 | +10.97% | 132 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $170 | $129.83 | +30.94% | 111 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $45 | $27.40 | +64.23% | 40 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $6.25 | +332.00% | 80 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.61 | +521.12% | 6 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.25 | +255.56% | 3 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $62 | $51.09 | +21.35% | 17 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $43 | $23.61 | +82.13% | 8 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $3.10 | +158.06% | 2 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $28.92 | +55.60% | 4 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 | $53.35 | n/a | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $123.54 | n/a | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.85 | n/a | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $24.17 | n/a | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $2.92 | n/a | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.54 | n/a | 73 | Jun 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $8.95 | n/a | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $59.12 | n/a | 1 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $23.53 | n/a | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.1 | $13.73 | n/a | 1 | Jul 2, 2019 |
Cytokinetics
Jun 23, 2026
Maintained: Buy
Price Target: $100 → $118
Current: $84.87
Upside: +39.04%
Kura Oncology
Jun 23, 2026
Maintained: Buy
Price Target: $25
Current: $11.45
Upside: +118.34%
Maze Therapeutics
Jun 23, 2026
Maintained: Buy
Price Target: $97
Current: $30.57
Upside: +217.30%
Iovance Biotherapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $10
Current: $4.23
Upside: +136.41%
Nkarta
Jun 22, 2026
Maintained: Buy
Price Target: $12
Current: $2.97
Upside: +304.04%
Amgen
Jun 21, 2026
Maintained: Hold
Price Target: $303
Current: $363.39
Upside: -16.62%
BridgeBio Pharma
Jun 21, 2026
Maintained: Buy
Price Target: $96
Current: $85.89
Upside: +11.77%
Incyte
Jun 18, 2026
Maintained: Buy
Price Target: $121
Current: $116.71
Upside: +3.68%
Atara Biotherapeutics
Jun 18, 2026
Maintained: Buy
Price Target: $18
Current: $9.76
Upside: +84.43%
Vaxcyte
Jun 18, 2026
Maintained: Buy
Price Target: $163
Current: $58.21
Upside: +180.02%
Jun 12, 2026
Rated: Buy
Price Target: $236 → $221
Current: $199.15
Upside: +10.97%
Jun 12, 2026
Maintained: Buy
Price Target: $170
Current: $129.83
Upside: +30.94%
Jun 12, 2026
Maintained: Buy
Price Target: $40 → $45
Current: $27.40
Upside: +64.23%
Jun 12, 2026
Maintained: Buy
Price Target: $27
Current: $6.25
Upside: +332.00%
Jun 10, 2026
Maintained: Buy
Price Target: $10
Current: $1.61
Upside: +521.12%
Jun 10, 2026
Maintained: Buy
Price Target: $8
Current: $2.25
Upside: +255.56%
Jun 2, 2026
Maintained: Buy
Price Target: $45 → $62
Current: $51.09
Upside: +21.35%
Mar 30, 2026
Maintained: Buy
Price Target: $45 → $43
Current: $23.61
Upside: +82.13%
Nov 14, 2025
Maintained: Buy
Price Target: $8
Current: $3.10
Upside: +158.06%
Aug 18, 2025
Maintained: Buy
Price Target: $45
Current: $28.92
Upside: +55.60%
May 20, 2025
Maintained: Buy
Price Target: $85
Current: $53.35
Upside: n/a
Nov 22, 2024
Rated: Hold
Price Target: n/a
Current: $123.54
Upside: n/a
Nov 22, 2024
Rated: Hold
Price Target: n/a
Current: $15.85
Upside: n/a
May 28, 2024
Maintained: Buy
Price Target: $53
Current: $24.17
Upside: n/a
Mar 25, 2024
Maintained: Buy
Price Target: $25
Current: $2.92
Upside: n/a
Jun 16, 2023
Rated: Hold
Price Target: n/a
Current: $1.54
Upside: n/a
Mar 6, 2023
Maintained: Buy
Price Target: $21
Current: $8.95
Upside: n/a
Nov 3, 2022
Maintained: Buy
Price Target: $23
Current: $59.12
Upside: n/a
Aug 4, 2022
Maintained: Buy
Price Target: $25
Current: $23.53
Upside: n/a
Jul 2, 2019
Maintained: Buy
Price Target: $7.1
Current: $13.73
Upside: n/a